Terguride—a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 49 (4) , 589-594
- https://doi.org/10.1016/s0015-0282(16)59823-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Clinical evaluation of lysuride in the management of hyperprolactinaemia.BMJ, 1987
- Measurement of circulating corticotrophin-releasing factor in manJournal of Endocrinology, 1987
- Chronic Treatment of Pathological Hyperprolactinemia and Acromegaly with the New Ergot Derivative Terguride*Journal of Clinical Endocrinology & Metabolism, 1986
- Effect of the new ergot derivative terguride on plasma PRL and GH levels in patients with pathological hyperprolactinemia or acromegalyJournal of Endocrinological Investigation, 1985
- Prolactinomas.BMJ, 1985
- Drugs Five Years LaterAnnals of Internal Medicine, 1984
- Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbineLife Sciences, 1982
- Pergolide Mesylate: Its Effects on Circulating Anterior Pituitary Hormones in Man*Journal of Clinical Endocrinology & Metabolism, 1981
- Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*Journal of Clinical Endocrinology & Metabolism, 1981
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964